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Most groups of psycho-education are currently based and
orientated toward the classical clinical picture of bipolarity,
“Bipolar-I Disorder”, which includes intense to severe
(hypo)mania phases (often leading to hospitalization).
However, the reality of clinical practice shows another evi-
dence: soft bipolar spectrum is probably the most frequent
expression of this disorder. More than 40% of major
depressions and 2/3 of recurrent or resistant depressions
are part of this spectrum, which seems to be highly but
neglected in pharmacological and especially in psychologi-
cal treatment processes.
The French multi-center national EPIDEP study showed
that cases classified as BP-II 1/2 (Major Depression plus
Cyclothymia) represent the most frequent disorder (33%
of all included depressives). Systematic inter-group com-
parison among the soft spectrum showed the heterogeneity
of the soft bipolar spectrum, with special characteristics for
“BP-II ½”. Repeated brief swings with high mood instabil-
ity and rapid switching seemed to be a distinct entity with
early onset, irritable (“dark”) hypomania and high suicide
risk. This condition emerged as the most prevalent and
severe expression of the bipolar spectrum.
Cyclothymia is a psychobiological disorder, with brain and
body disturbances. It can disturb all life aspects, even daily
routines, with important consequences such as failures, iso-
lation, job loss and severe interpersonal conflicts. When
untreated cyclothymia can put subject life in danger. Most
clinicians still of focus on depression, comorbid anxiety or
personality disorders, and usually stay blind to
cyclothymia.
Initiated by E.G.Hantouche, a psycho-education group
model has been elaborated with the help of V. Trybou and
C. Majdalani. The model was build on the conception of
Cyclothymia as a basic predisposition and not as a minor
form of bipolarity. The format is weekly based on six ses-
sions of 2 hours each. To be included, patient must present
a bipolar II ½ disorder: persistent and significant
cyclothymic trait (score 10 or more on questionnaire
TEMPS-A). The group therapy offers to patients the oppor-
tunity to get information on soft bipolar spectrum by shar-
ing life experiences with other patients, and getting support
from them and from psychologists. The major key points of
psycho-education group are listed below:
- Learning about cyclothymia: clinical aspects, specificity,
co-morbidity, causes, medication, symptoms
- Monitoring and self assessment of Cyclothymia and warn-
ing signs, coping with early relapses, and planning of daily
activities and rhythms
- Getting familiar with psychological vulnerabilities: sensi-
tivity to rejection, obsessive need to please, testing limits,
hyper-control, compulsive behaviors, emotional depend-
ency
- Getting access to the cognitive processes linked to emo-
tional disturbances
- Dealing with daily interpersonal conflicts
- Nurturing positive aspects of cyclothymia and own crea-
tivity
During the presentation, open data concerning six consec-
utive groups therapy will be presented and future orienta-
tions will be emphasized.
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